Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo

G Jansen; G J Peters; H M Pinedo; D G Priest; Y G Assaraf

Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo

G Jansen, G J Peters, H M Pinedo, D G Priest, Y G Assaraf

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2047-50
Number of pages	4
Journal	Journal of the National Cancer Institute
Volume	91
Issue number	23
Publication status	Published - 1 Dec 1999

Cite this

@article{ace217c5d60a483a91a078eb2c41988f,

title = "Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo",

keywords = "Animals, Antimetabolites, Antineoplastic/therapeutic use, Enzyme Inhibitors/therapeutic use, Folic Acid Antagonists/therapeutic use, Gene Transfer Techniques, Genetic Therapy, Glioma/enzymology, Humans, Peptide Synthases/genetics, Tumor Cells, Cultured",

author = "G Jansen and Peters, {G J} and Pinedo, {H M} and Priest, {D G} and Assaraf, {Y G}",

year = "1999",

month = dec,

day = "1",

language = "English",

volume = "91",

pages = "2047--50",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "23",

}

TY - JOUR

T1 - Re

T2 - Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo

AU - Jansen, G

AU - Peters, G J

AU - Pinedo, H M

AU - Priest, D G

AU - Assaraf, Y G

PY - 1999/12/1

Y1 - 1999/12/1

KW - Animals

KW - Antimetabolites, Antineoplastic/therapeutic use

KW - Enzyme Inhibitors/therapeutic use

KW - Folic Acid Antagonists/therapeutic use

KW - Gene Transfer Techniques

KW - Genetic Therapy

KW - Glioma/enzymology

KW - Humans

KW - Peptide Synthases/genetics

KW - Tumor Cells, Cultured

M3 - Article

C2 - 10580033

SN - 0027-8874

VL - 91

SP - 2047

EP - 2050

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 23

ER -